Compass Pathways Appoints Kelley Boucher as Chief People Officer
Compass Pathways appointed Kelley Boucher as Chief People Officer, effective immediately, as the company scales toward its planned commercial phase. Boucher previously served as Chief People Officer at Apellis and CHRO at Alnylam, bringing two decades of biotech HR leadership during commercial transitions.
Key figures
- Guidance
- NDA submission for COMP360 psilocybin in TRD planned Q4 2026; commercial launch targeted H1 2027, subject to FDA approval
- Launch target
- H1 2027
- Nda submission timing
- Q4 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.